Hope in Action: ULF Board Member’s Son Receives World’s First SLC6A1 Treatment
We are excited to share a powerful new People Magazine feature highlighting our ULF Board Member Amber Freed and her son Maxwell, and the extraordinary journey that led to a groundbreaking milestone in rare disease history. In the article, Amber’s son Maxwell is described as having a neurodevelopmental condition known as SLC6A1, a rare genetic …
Hope in Action: ULF Board Member’s Son Receives World’s First SLC6A1 Treatment Read More »
